Skip to content

Prediction of the diagnosis, subtype, and prognosis of ADHD using multimodal imaging genetic data

Prediction of the diagnosis, subtype, and prognosis of ADHD using multimodal imaging genetic data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078456
Enrollment
Unknown
Registered
2023-12-08
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Interventions

Gold Standard:The ADHD participants were divided into two sub-groups: medication responders, who have a reduction rate of over 25% of the total score of the ADHD rating scale after 12 weeks of pharmac
Index test:Use Independent component analysis (ICA) for the data reduction of the imaging genetic measures, e.g., polygenic risk score, cortical thickness/surface area/BOLD signal of the frontal lobe,

Sponsors

Shenzhen Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 9 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for the ADHD group are as follows: (1) A clinical diagnosis of ADHD based on DSM-5 and semi-structured interview by K-SADS-PL; (2) Aged 6-9 years; (3) Normal full-scale intelligence quotient (IQ) measured by the Wechsler Intelligence Scale for Chinese Children-IV (WISC-IV) (=80); (4) Normal Vision or normal corrected vision; (5) Right-hand dominant; (6) No visible brain abnormalities on the MRI images, e.g., arachnoid cyst; (7) No past or current history of contraindication for MRI, e.g., claustrophobia; As for the control group, the inclusion and exclusion criteria are the same as the ADHD group except for the diagnosis of ADHD.

Exclusion criteria

Exclusion criteria: The exclusion criteria for the ADHD and the Control group include: (1) A history of head injury with loss of consciousness; (2) Any drug or substance misuse; (3) A present or past diagnosis of other psychiatric disorder (comorbiding CD and ODD is allowed in the ADHD group); (4) History of using prescribed medications for ADHD or other psychiatric disorders;

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;

Countries

China

Contacts

Public ContactZhaomin Wu

Shenzhen Children's Hospital

zhaomin.wu@foxmail.com+86 186 1708 7238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026